American Shared Hospital Services ( (AMS) ) has released its Q3 earnings. Here is a breakdown of the information American Shared Hospital Services presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
American Shared Hospital Services (AMS) is a prominent provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, operating primarily in the healthcare sector through equipment leasing and direct patient care services.
In its third quarter of 2025, AMS reported a 2.5% increase in revenue compared to the same period last year, alongside a significant 42.3% growth in EBITDA. The company also announced a 10-year extension with an existing health system and an upgrade to their Gamma Knife system.
Key financial highlights include a 9.4% increase in direct patient services revenue and a notable reduction in net loss by 91.8% to $17,000 from $207,000 in the previous year. The company’s gross margin improved to 22.1%, driven by higher treatment volumes, while the direct patient care services segment accounted for 56% of total sales, up from 53% last year. However, the equipment leasing segment saw a decline due to lower PBRT volumes.
Looking ahead, AMS management remains optimistic about continued growth, with plans to expand their footprint in Rhode Island and Mexico. The company is focused on strategic initiatives to enhance efficiency and leverage economies of scale, positioning itself for robust long-term growth and profitability.